Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

512 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00003960

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

Center for Cancer Treatment and Research Columbia, South Carolina, United States

View Trial Details

Completed

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00003962

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +50 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma

NCT01220375

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Dep. of Medical Oncology, Bern University Hospital Bern, Switzerland

View Trial Details

Completed

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00265837

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00033332

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States

Stanford University Medical Center Stanford, California, United States

View all 78 locations

View Trial Details

Completed

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

NCT00890747

Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
Locations: Jonsson Comprehensive Cancer Center Los Angeles, California, United States

Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States

Northwestern University Chicago, Illinois, United States

AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States

View Trial Details

Completed

Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004145

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +52 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma

NCT00725634

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Investigational Site 2 Scottsdale, Arizona, United States

Investigational Site 3 Columbus, Ohio, United States

Investigational Site 1 San Antonio, Texas, United States

View Trial Details

Completed

Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma

NCT00060203

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Ireland Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma

NCT00499577

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States

Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Neoplasms, Plasma Cell

Neoplasms, Plasma Cell trial results

Related conditions